SETD2 and neoplasm: ACF is a drug that prevents HIF-1 α dimerization, which inhibits HIF-1 α DNA binding and subsequent transcriptional activity, resulting in tumor growth inhibition, circulating angiogenic cells (CACs) mobilization, and tumor vascularization [127,174].